Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.
about
Role of microglia in central nervous system infectionsBiomarkers of Alzheimer's diseaseFlavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related DiseasesNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseEnvironmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseasesMicroglia are crucial regulators of neuro-immunity during central nervous system tuberculosisHunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse modelInflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cellsRole of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brainPhagocytosis of microglia in the central nervous system diseasesPeripheral blood mononuclear cells as a laboratory to study dementia in the elderly.Cross-talk between IGF-1 and estrogen receptors attenuates intracellular changes in ventral spinal cord 4.1 motoneuron cells because of interferon-gamma exposure.Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrowThe role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade.Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosisTemporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits.Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantationThe inflammatory response in Alzheimer's disease.Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells.Inflammation induced by infection potentiates tau pathological features in transgenic mice.Activated scavenger receptor A promotes glial internalization of aβSustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia.Increased Acetylation of Histone H4 at Lysine 12 (H4K12) in Monocytes of Transgenic Alzheimer's Mice and in Human Patients.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?Clinical aspects of inflammation in Alzheimer's disease.Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia.Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population.Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophagesEstrogen action in neuroprotection and brain inflammation.
P2860
Q24563024-D79BEC35-2E7E-4E25-A661-F14EAE5053A4Q24650667-CAE4938E-A474-47F5-8773-28EB1B254D0FQ26746303-82475A73-4B71-425F-930D-D0C0FEBA3198Q26783306-2A8E970C-409E-4EEF-9FC3-1222AFCB2ECFQ26821835-207E7CD2-EE10-4CD6-BB64-6DDA3CF95FCCQ28082627-9883A708-EABA-4A80-ABEF-062C8E8F742FQ28485899-68B541A5-0020-4929-9155-F58A8D3DB6F7Q28572077-3A103F88-9D39-4BEC-AA9D-CFA3EB0EE4C3Q30490518-A9786A3A-0E20-4F64-BF80-FB124FD26193Q30542245-F4D9D034-77F8-4919-8924-D7A5EB2D8A70Q33574527-91451EBD-A701-4A73-B8B4-639D1F7112FFQ33616120-AE12D22B-D4BD-4491-BC33-29470A5FA62FQ33869940-2B64E663-D7D1-492E-9EC1-3298F490A84DQ33926543-279BBD5A-DBF9-4522-90FB-31C65194203DQ33947287-21F8714C-B4FA-4C6F-88AF-CBD76DA7A7B4Q34104401-E3F7B8DF-FDFB-4918-AEAC-6DD994A67519Q34393160-8D5AE8AA-DF13-42E6-8E68-83B1FB17F2F6Q34545200-945FDCDC-1452-4F92-A969-F9D462F42FD2Q34554154-9C18DE51-FFB7-43FD-8A52-A7B6C3AAE194Q34695511-7E869717-99C3-4E67-9C0D-F4E5E9CC7853Q34764098-1122F0D4-C0B0-4D7F-B246-798A22E8F47FQ34803247-4AA6E434-B279-40EF-8812-E6D246962410Q34983243-C2D396E2-3E53-43E1-98B7-8956A12BFB70Q35013183-A58AFAF7-4A71-41BE-AADD-8A468EF89D65Q35071072-242427A9-7ABB-4E87-92E9-4D2C11217580Q35144086-D14EB2DF-4698-4EC9-82CF-A15011DCDBD8Q35813745-49516F9E-7578-4C8F-BF93-F82CE0F6A6B6Q35818467-22CB9050-882A-4789-9608-89996E07B18CQ36008864-AD7E6BD3-4E56-4AF6-A85D-2F2CBD85F354Q36108218-2CA61246-B581-49F0-9D02-59D065242CABQ36121377-4DB15EAB-FA71-4A3A-942C-271542364E4FQ36266206-1405242B-D35C-4ABA-9580-2A900CF4A858Q36364213-7A104DF7-AC3C-4461-B68B-B4960755D2ACQ36402221-F654224C-19AA-439E-AC8E-656DB2F0A381Q36465550-AC8BFBD6-FAD5-40ED-8362-3252DBA4E538Q36469146-21A535B8-19D1-40CF-B151-B22E73611260Q36571241-978035E3-AF2F-4611-85D1-8D7CB51297F4Q36597635-1E7454F8-141C-4CDF-89F8-37AF1158A50CQ36713193-BC26495B-B36F-4059-BE7B-2663CCC4CF3FQ36721776-2911C9DF-C29F-422E-9385-620DD310A031
P2860
Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@ast
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@en
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@nl
type
label
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@ast
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@en
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@nl
prefLabel
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@ast
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@en
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@nl
P921
P1476
Microglial chemotaxis, activat ...... nomena in Alzheimer's disease.
@en
P304
P356
10.1016/S0197-0186(01)00040-7
P577
2001-11-01T00:00:00Z